Product Information

HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Padagis US LLC, priced at $6.0373 per EA under NDC 00574029301. Its NADAC has been published 252 times since Jun 17, 2015.

The High Outlier badge above means this manufacturer's average price in the hydromorphone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROMORPHONE HCL ER 8 MG TAB

hydromorphone hydrochloride
$6.0373per EA
High Outlier
DEA Schedule CII

Strength

8 mg/1

Manufacturer

Padagis US LLC

NDC

00574029301

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204278

On Market Since

5/22/2015

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 252 times since Jun 17, 2015, and over the history we have for it it has declined 44.3%. The table below summarizes its recorded NADAC range and movement.

Current price$6.0373 per EA
All-time high$10.8378 (Jul 15, 2015)
All-time low$6.0373 (Jun 17, 2026)
52-week high$7.0165
52-week low$6.0373
Median price$8.3953
Average price$8.2033
Largest weekly change-24.6% (Jan 17, 2018)
Weeks tracked252
Tracking sinceJun 17, 2015

Price History

1W

0.0%

1M

-6.2%

3M

-14.0%

6M

-5.7%

1Y

-13.7%

3Y

-13.7%

5Y

-13.7%

All

-44.3%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Padagis US LLC, is $6.0373 per EA (NDC 00574029301), effective Jun 24, 2026.

How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has declined 44.3%. It has been tracked across 252 weekly CMS publications since Jun 17, 2015.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?

Since Jun 17, 2015, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $6.0373 (Jun 17, 2026) to a high of $10.8378 (Jul 15, 2015), with a median of $8.3953 per EA.

Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?

Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5665 per EA — about 91% below HYDROMORPHONE HCL ER 8 MG TAB.

Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?

HYDROMORPHONE HCL ER 8 MG TAB (NDC 00574029301) is labeled by Padagis US LLC, and CMS classifies it as a generic product.